Local cytokine messenger ribonucleic acid expression and in vitro allergic late phase responses in Brown-Norway rats

European Respiratory Journal

Volumn 11, Issue 3, 1998, Pages 630-635

  Minshall, E M ^a   Dandurand, R J ^a   Hamid, Q ^a   Eidelman, D H ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cytokines; Late airway response; Lung explants; Lymphocytes; Mast cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; OVALBUMIN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; LYMPHOCYTE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS; ASTHMA; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LUNG; OVALBUMIN; RATS; RATS, INBRED BN; RNA, MESSENGER; TIME FACTORS;

EID: 0031925950     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Walker C, Kaegi MK, Braun P, Blaser K. Activated T-cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935-942.
2. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T-lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142; 1407-1413.
3. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87: 1541-1546.
4. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for Th2-type (interleukin-4 and interleukin-5) and Th1-type (interleukin-2 and interferon-γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995; 12: 477-487.
5. Clutterbuck EJ, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 1989; 73: 1504-1512.
6. Yamaguchi Y, Hayashi Y, Sugama Y, et al. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 1988; 167: 1737-1742.
7. Del Prete G, Maggi E, Parronchi P, et al. IL-4 is an essential co-factor for the IgE synthesis induced in vitro by human T-cell clones and their supernatants. J Immunol 1988; 140: 4193-4198.
8. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993; 147: 901-907.
9. Eidelman DH, Minshall E, Dandurand RJ, et al. Evidence for major basic protein immunoreactivity and IL-5 gene activation during the late phase response in explanted airways. Am J Respir Cell Mol Biol 1996; 15: 582-589.
10. Zangrilli JG, Shaver JR, Cirelli RA, et al. sVCAM-1 levels after segemental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med 1995; 151: 1346-1353.
11. Dandurand RJ, Wang CG, Laberge S, Martin JG, Eidelman DH. In vitro allergic bronchoconstriction in the Brown Norway rat. Am J Respir Crit Care Med 1994; 149: 1499-1505.
12. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T-cells, increased Th2-type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92: 313-324.
13. Eidelman DH, Bellofiore S, Martin JG. Late airway responses to antigen challenge in sensitized inbred rats. Am Rev Respir Dis 1988; 137(5): 1033-1037.
14. Olivenstein R, Renzi PM, Yang JP, et al. Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats. J Clin Invest 1993; 92(3): 1477-1482.
15. Waserman S, Olivenstein R, Renzi P, Xu LJ, Martin JG. The relationship between late asthmatic responses and antigen-specific immunoglobulin. J Allergy Clin Immunol 1992; 90: 661-669.
16. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T-lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5, granulocyte-macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthma. Am J Respir Cell Mol Biol 1993; 8: 35-42.
17. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow J-C. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146: 109-115.
18. 2. Proc Natl Acad Sci USA 1988; 85: 6880-6884.
19. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone diproprionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987; 79: 734-740.
20. Van Bever HP, Stevens WJ. Evolution of the late asthmatic response during immunotherapy and after stopping immunotherapy. J Allergy Clin Immunol 1990; 86: 141-146.
21. Robinson DS, Hamid Q, Ying S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5 and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993; 148: 401-408.
22. Varney VA, Hamid Q, Bentley AM, Ying S, Kay AB, Durham SR. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993; 92: 313-324.
23. Kay AB, Ying S, Varney V, et al. Messenger RNA expression of the cytokine gene cluster, interleukin-3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173: 775-778.
24. Aalbers R, Kauffman HF, Vrugt B, et al. Bronchial lavage and bronchoalveolar lavage in allergen-induced single early and dual asthmatic responders. Am Rev Respir Dis 1993; 147: 76-81.
25. De Monchy JGR, Kauffman HF, Venge P, et al. Broncho-alveolar eosinophilial during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373-376.
26. Rossi GA, Crimi E, Lantero S, et al. Late phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. Am Rev Respir Dis 1991; 144: 379-383.
27. Maggi E, Parronchi P, Manetti R, et al. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of Th1 and Th2 clones. J Immunol 1992; 148: 2142-2147.
28. Bradding P, Roberts JA, Britten KM, et al. Interleukin-4, -5 and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10: 471-480.
29. Okayama Y, Petit-Frere C, Kassel O, et al. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol 1995; 155(4): 1796-1808.
30. MacGlashan DW, White JM, Huang S-K, Ono SJ, Schroeder JT, Lichtenstein LM. Secretion of IL-4 from human basophils: the relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 1994; 152: 3006-3016.